Neos Investment Management LLC Silence Therapeutics PLC Transaction History
Neos Investment Management LLC
- $2.43 Trillion
- Q2 2024
A detailed history of Neos Investment Management LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Neos Investment Management LLC holds 37,164 shares of SLN stock, worth $715,407. This represents 0.03% of its overall portfolio holdings.
Number of Shares
37,164
Previous 11,656
218.84%
Holding current value
$715,407
Previous $252 Million
180.46%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
71Shares Held
27.1MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.3MShares$63.4 Million9.38% of portfolio
-
Artal Group S.A. Luxembourg, N42.78MShares$53.5 Million3.35% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.41MShares$46.3 Million3.46% of portfolio
-
Redmile Group, LLC San Francisco, CA2.01MShares$38.8 Million2.5% of portfolio
-
Logos Global Management LP San Francisco, CA1.48MShares$28.4 Million2.63% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $691M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...